Accessibility Menu
Arrow-Thin-Down
S&P 500
6,734.11
-0.1%
-3.38
Arrow-Thin-Down
DJI
47,147.48
-0.7%
-309.74
Arrow-Thin-Down
NASDAQ
22,900.59
+0.1%
+30.23
Arrow-Thin-Down
Bitcoin
$95,137.00
-0.8%
-$743.86
Arrow-Thin-Down
AAPL
$272.41
-0.2%
-$0.54
Arrow-Thin-Down
AMZN
$234.69
-1.2%
-$2.89
Arrow-Thin-Down
GOOG
$276.98
-0.8%
-$2.14
Arrow-Thin-Down
META
$609.46
-0.1%
-$0.43
Arrow-Thin-Down
MSFT
$510.18
+1.4%
+$6.89
Arrow-Thin-Down
NVDA
$190.00
+1.7%
+$3.14
Arrow-Thin-Down
TSLA
$404.35
+0.6%
+$2.36
Daily Stock GainersDaily Stock LosersMost Active Stocks

Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket

By Jose Najarro – Jul 12, 2023 at 4:55PM

Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday.

In this video, I will discuss the recent updates impacting Nvidia (NVDA +1.68%) and Recursion Pharmaceuticals (RXRX 4.39%). Check out the short video to learn more, consider subscribing, and click the special offer link below.

*Stock prices used were the market prices of July 12, 2023. The video was published on July 12, 2023.

About the Author

Jose Najarro
Jose Najarro enjoys investing in the tech market, more importantly, the semiconductor sector. Before partnering with the Fool, Jose worked as a Senior Electrical Engineer for General Dynamics, where he had first-hand experience seeing how emerging technology can change the world. Jose Najarro went to NJIT, receiving his Bachelor's and Master's degree in Electrical Engineering.
TMFJoseYT
X@_JoseNajarro

Jose Najarro has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Jose Najarro is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services